Ark Invest, through its ARK Fintech Innovation ETF ARKF -5.46% + Free Alerts , bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
EST Cathie Wood’s ARK Investment buys 171K shares of Beam Therapeutics (BEAM) todayDiscover the Best Stocks and Maximize Your Portfolio: ...
Thirty years ago today, 'Eye of the Needle' gave Voyager an impossible scenario, and gave it a perfectly Star Trek solution.
The Brighterside of News on MSN3d
New proton beam therapy precisely targets and destroys cancer cellsGlioblastoma, the most common and lethal form of primary brain cancer, presents daunting challenges. Each year, around 14,500 people in the United States face this aggressive disease. Its invasive ...
Zacks.com on MSN5d
CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?CRISPR Therapeutics CRSP stock rose more than 25% in the past week, thanks to the encouraging fourth-quarter 2024 results and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback